The trial will study 8,000 patients with stable ischemic heart disease and moderate to sever ischemia, the release said. The strategies to be investigated are whether an early invasive strategy with cardiac catheterization followed by revascularization and optimal medical therapy produces better results than a simply using OMT. It will also assess whether the invasive strategy improves “angina-related quality of life.”
Read the news release on NYU Langone Medical Center.
Related Articles on Hospital Cardiology:
Virginia’s Valley Health Acquires Cardiology Group
Retired Cardiologist Convicted, Faces up to 35 Years in Prison for Unnecessary Stents, Fraudulent Billing
Ohio Heart and Vascular Center Opens Heart Failure Clinic
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
